|
As a new biomaterial BioSilicon™ is a nanostructured
form of elemental silicon, one of the most abundant elements
on the earth's crust, engineered to create a ‘honeycomb'
structure of pores. This structure allows silicon to biodegrade
while also allowing the retention of various drugs and vaccines
within the honeycomb matrix. BioSilicon™ retains the
key semiconductor properties of silicon and is machineable
at a micro level. BioSilicon™ also demonstrates optical
properties that provide the basis for a variety of potential
devices for biodegradable and biocompatible diagnostic products.
In pre-clinical studies pSivida has shown that BioSilicon™ is
both biodegradable and biocompatible. pSivida believes that
in doing so it has created a unique biomaterial that has
the potential not only to serve as a biomedical device but
also as a novel drug delivery carrier for a wide range of
drug entities. pSivida's studies have shown that BioSilicon™ dissolves
in body fluids into silicic acid, commonly found in everyday
foods.
pSivida's core focus is the development of applications
for controlled release drug delivery. Other potential applications
across the healthcare sector include diagnostics, targeted
cancer therapies (including brachytherapy and localized chemotherapy),
orthopedics, tissue engineering and ophthalmology.
Porous
membrane of BioSilicon™ [cross section] |
competitive
advantages of biosilicon™
|